A detailed history of Ifrah Financial Services, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Ifrah Financial Services, Inc. holds 3,431 shares of JNJ stock, worth $565,497. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,431
Previous 3,508 2.19%
Holding current value
$565,497
Previous $554,000 9.57%
% of portfolio
0.14%
Previous 0.16%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$144.38 - $157.78 $11,117 - $12,149
-77 Reduced 2.19%
3,431 $501,000
Q1 2024

May 06, 2024

BUY
$155.22 - $162.74 $20,333 - $21,318
131 Added 3.88%
3,508 $554,000
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $35,089 - $38,290
-241 Reduced 6.66%
3,377 $529,000
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $18,690 - $20,937
-120 Reduced 3.21%
3,618 $563,000
Q2 2023

Aug 01, 2023

BUY
$154.35 - $166.11 $7,871 - $8,471
51 Added 1.38%
3,738 $618,000
Q1 2023

May 04, 2023

SELL
$151.05 - $180.26 $43,351 - $51,734
-287 Reduced 7.22%
3,687 $571,000
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $5,607 - $6,292
-35 Reduced 0.87%
3,974 $702,000
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $645 - $718
-4 Reduced 0.1%
4,009 $655,000
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $5,213 - $5,766
-31 Reduced 0.77%
4,013 $712,000
Q1 2022

May 03, 2022

BUY
$158.14 - $179.59 $3,637 - $4,130
23 Added 0.57%
4,044 $717,000
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $7,796 - $8,650
50 Added 1.26%
4,021 $688,000
Q3 2021

Nov 01, 2021

BUY
$161.5 - $179.47 $2,584 - $2,871
16 Added 0.4%
3,971 $641,000
Q2 2021

Aug 05, 2021

SELL
$159.48 - $171.07 $27,271 - $29,252
-171 Reduced 4.14%
3,955 $652,000
Q1 2021

Apr 30, 2021

BUY
$153.07 - $170.48 $194,858 - $217,021
1,273 Added 44.62%
4,126 $678,000
Q4 2020

Feb 05, 2021

SELL
$137.11 - $157.38 $959 - $1,101
-7 Reduced 0.24%
2,853 $449,000
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $982 - $1,076
7 Added 0.25%
2,860 $426,000
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $367,494 - $443,670
2,853 New
2,853 $401,000
Q3 2019

Nov 04, 2019

SELL
$126.95 - $142.14 $186,616 - $208,945
-1,470 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$125.72 - $139.79 $184,808 - $205,491
1,470 New
1,470 $205,000
Q4 2018

May 13, 2019

SELL
$122.84 - $147.84 $180,574 - $217,324
-1,470 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$121.58 - $142.88 $178,722 - $210,033
1,470 New
1,470 $203,000
Q2 2018

Aug 01, 2018

SELL
$119.4 - $131.76 $473,659 - $522,691
-3,967 Closed
0 $0
Q1 2018

May 03, 2018

SELL
$125.1 - $148.14 $2,376 - $2,814
-19 Reduced 0.48%
3,967 $508,000
Q4 2017

Feb 01, 2018

BUY
$131.22 - $143.62 $1,837 - $2,010
14 Added 0.35%
3,986 $557,000
Q3 2017

Nov 06, 2017

BUY
$129.47 - $135.38 $514,254 - $537,729
3,972
3,972 $516,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ifrah Financial Services, Inc. Portfolio

Follow Ifrah Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifrah Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ifrah Financial Services, Inc. with notifications on news.